Efficacy of Tadalafil on Improvement of Men with Erectile Dysfunction Caused by COVID-19: A Randomized Placebo-controlled Trial

Overview

Journal Asian J Urol

Specialty Urology

Date 2022 Aug 22

PMID 35992730

Authors

Iman Shamohammadi

Seyedmohammad Kazemeyni

Mohammadali Sadighi

Tara Hasanzadeh

Alireza Dizavi

Affiliations

Soon will be listed here.

Abstract

Objective: According to the high prevalence of coronavirus disease (COVID-19) and the subsequent risk of men's sexual health, we decided to investigate the efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19.

Methods: In this study, 70 outpatients who were recovered from COVID-19 without acute respiratory distress syndrome with negative polymerase chain reaction test and a complaint of erectile dysfunction were divided into two groups: 35 patients who received tadalafil 5 mg daily and 35 who received placebo. For each patient, basic assessment of sexual function was performed using the 5-item version of the International Index of Erectile Function (IIEF) questionnaire. Then, treatment was started from two months after complete recovery of COVID-19 with negative polymerase chain reaction test for 3 months. At the end of the treatments, the patients were re-evaluated for sexual function using the complete version of IIEF questionnaire. Finally, the results before and after treatment in the intervention group were compared with those of the control group.

Results: Treatment with both tadalafil and placebo improved the patients' sexual function criteria compared to the baseline. However, this improvement was significantly higher in the intervention group with tadalafil than the control group with placebo (<0.05).

Conclusions: Daily administration of tadalafil 5 mg seems to be effective and safe for improvement of erectile dysfunction caused by COVID-19.

Citing Articles

COVID-19 infection may reduce serum testosterone levels and increase the risk of erectile dysfunction: A two-sample Mendelian randomization study.

Wang T, Li C, Song J Investig Clin Urol. 2025; 66(2):152-160.

PMID: 40047129 PMC: 11885915. DOI: 10.4111/icu.20240384.

Investigating functionality and taste assessment of eco-friendly Tadalafil Pastilles.

Rana H, Panchal M, Thakkar V, Gandhi T, Dholakia M Heliyon. 2024; 10(8):e29543.

PMID: 38660288 PMC: 11040062. DOI: 10.1016/j.heliyon.2024.e29543.

References

Corona G, Rastrelli G, Ricca V, Jannini E, Vignozzi L, Monami M . Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction. J Sex Med. 2013; 10(4):1074-89. DOI: 10.1111/jsm.12043. View

Maiorino M, Bellastella G, Giugliano D, Esposito K . From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest. 2018; 41(11):1249-1258. DOI: 10.1007/s40618-018-0872-6. View

Yafi F, Jenkins L, Albersen M, Corona G, Isidori A, Goldfarb S . Erectile dysfunction. Nat Rev Dis Primers. 2016; 2:16003. PMC: 5027992. DOI: 10.1038/nrdp.2016.3. View

Graney B, Wamboldt F, Baird S, Churney T, Fier K, Korn M . Looking ahead and behind at supplemental oxygen: A qualitative study of patients with pulmonary fibrosis. Heart Lung. 2017; 46(5):387-393. DOI: 10.1016/j.hrtlng.2017.07.001. View

Hamilton L, Meston C . Chronic stress and sexual function in women. J Sex Med. 2013; 10(10):2443-54. PMC: 4199300. DOI: 10.1111/jsm.12249. View

Mostafa T . Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?. Sex Med Rev. 2020; 9(1):15-22. PMC: 7833179. DOI: 10.1016/j.sxmr.2020.08.006. View

Mollaioli D, Ciocca G, Limoncin E, Di Sante S, Gravina G, Carosa E . Lifestyles and sexuality in men and women: the gender perspective in sexual medicine. Reprod Biol Endocrinol. 2020; 18(1):10. PMC: 7025405. DOI: 10.1186/s12958-019-0557-9. View

Omar S, Dawood W, Eid N, Eldeeb D, Munir A, Arafat W . Psychological and Sexual Health During the COVID-19 Pandemic in Egypt: Are Women Suffering More?. Sex Med. 2021; 9(1):100295. PMC: 7794051. DOI: 10.1016/j.esxm.2020.100295. View

Burnett A . Phosphodiesterase 5 mechanisms and therapeutic applications. Am J Cardiol. 2006; 96(12B):29M-31M. DOI: 10.1016/j.amjcard.2005.07.008. View

10.

Pal R, Banerjee M . COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020; 43(7):1027-1031. PMC: 7195612. DOI: 10.1007/s40618-020-01276-8. View

11.

Sansone A, Mollaioli D, Ciocca G, Limoncin E, Colonnello E, Vena W . Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. J Endocrinol Invest. 2020; 44(2):223-231. PMC: 7355084. DOI: 10.1007/s40618-020-01350-1. View

12.

Peng Z, Yang L, Dong Q, Wei Q, Liu L, Yang B . Efficacy and Safety of Tadalafil Once-a-Day versus Tadalafil On-Demand in Patients with Erectile Dysfunction: A Systematic Review and Meta-Analyses. Urol Int. 2017; 99(3):343-352. DOI: 10.1159/000477496. View

13.

Bruzziches R, Francomano D, Gareri P, Lenzi A, Aversa A . An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors. Expert Opin Pharmacother. 2013; 14(10):1333-44. DOI: 10.1517/14656566.2013.799665. View

14.

Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020; 26(8):1200-1204. DOI: 10.1038/s41591-020-0965-6. View

15.

Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

16.

Yuksel B, Ozgor F . Effect of the COVID-19 pandemic on female sexual behavior. Int J Gynaecol Obstet. 2020; 150(1):98-102. PMC: 9087619. DOI: 10.1002/ijgo.13193. View

17.

Oran D, Topol E . Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review. Ann Intern Med. 2020; 173(5):362-367. PMC: 7281624. DOI: 10.7326/M20-3012. View

18.

Zhang H, Penninger J, Li Y, Zhong N, Slutsky A . Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020; 46(4):586-590. PMC: 7079879. DOI: 10.1007/s00134-020-05985-9. View

19.

Liu P, Blet A, Smyth D, Li H . The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020; 142(1):68-78. DOI: 10.1161/CIRCULATIONAHA.120.047549. View

20.

Porst H, Burnett A, Brock G, Ghanem H, Giuliano F, Glina S . SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med. 2013; 10(1):130-71. DOI: 10.1111/jsm.12023. View